Design and synthesis of small molecules and nanoparticle conjugates for cell type-selective delivery
Histone deacetylase (HDAC) inhibition is an emerging novel therapeutic strategy in cancer therapy. HDAC inhibitors (HDACi) have shown ability to block angiogenesis and cell cycling, as well as initiate differentiation and apoptosis. In fact, suberoylanilide hydroxamic acid (SAHA) is the first in t...
Main Author: | |
---|---|
Published: |
Georgia Institute of Technology
2009
|
Subjects: | |
Online Access: | http://hdl.handle.net/1853/28111 |